China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000011K8
CNY
25.66
-0.06 (-0.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
8,129.84
9,616.17
7,176.24
7,956.50
6,775.51
7,876.32
5,582.59
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
8,129.84
9,616.17
7,176.24
7,956.50
6,775.51
7,876.32
5,582.59
Raw Material Cost
3,440.58
4,531.23
3,562.90
3,801.49
3,325.61
4,040.14
2,876.25
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
32.08
35.76
32.30
27.89
21.68
14.58
22.34
Selling and Distribution Expenses
2,719.99
3,406.98
2,520.50
2,858.09
1,759.00
2,975.19
1,831.50
Other Expenses
30.95
33.28
28.99
25.21
8.83
25.06
13.90
Total Expenditure (Excl Depreciation)
6,502.16
8,306.79
6,405.55
6,939.58
5,194.56
7,280.52
4,869.10
Operating Profit (PBDIT) excl Other Income
1627.7
1309.4
770.6999999999999
1016.9
1580.9
595.8
713.5
Other Income
51.10
168.07
103.74
133.02
101.31
173.75
168.06
Operating Profit (PBDIT)
1,561.92
1,755.08
1,173.98
1,294.14
1,997.26
842.20
1,082.24
Interest
32.08
35.76
32.30
27.89
21.68
14.58
22.34
Exceptional Items
56.39
119.81
104.95
36.68
0.50
9.56
-2.26
Gross Profit (PBDT)
4,689.26
5,084.95
3,613.34
4,155.02
3,449.91
3,836.19
2,706.34
Depreciation
0.00
408.33
408.33
306.91
306.91
228.76
228.76
Profit Before Tax
1,586.22
1,430.81
838.30
996.02
1,669.18
608.43
828.89
Tax
384.80
166.80
117.51
80.80
333.00
75.98
157.78
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,075.86
1,068.17
537.57
545.18
1,270.07
408.06
561.47
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,075.86
1,068.17
537.57
545.18
1,270.07
408.06
561.47
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
133.56
198.49
150.14
335.03
61.30
124.97
106.19
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,209.42
1,266.67
687.71
880.21
1,331.38
533.02
667.66
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
23,245.72
22,171.74
21,115.69
21,340.22
21,178.18
19,903.11
20,532.69
Earnings per share (EPS)
0.65
0.64
0.32
0.33
0.76
0.25
0.34
Diluted Earnings per share
0.65
0.64
0.32
0.33
0.76
0.25
0.34
Operating Profit Margin (Excl OI)
18.58%
12.26%
9.22%
10.74%
23.45%
5.58%
12.28%
Gross Profit Margin
19.51%
19.13%
17.37%
16.38%
29.17%
10.63%
18.95%
PAT Margin
13.23%
11.11%
7.49%
6.85%
18.75%
5.18%
10.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -15.46% vs 34.00% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -4.52% vs 84.19% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -4.80% vs 48.29% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -10.34% vs 10.84% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
8,129.84
0
8,129.84
Other Operating Income
0.00
0.00
0.00
Total Operating income
8,129.84
0
8,129.84
Raw Material Cost
3,440.58
0
3,440.58
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
32.08
0
32.08
Selling and Distribution Expenses
2,719.99
0
2,719.99
Other Expenses
30.95
0.00
30.95
Total Expenditure (Excl Depreciation)
6,502.16
0
6,502.16
Operating Profit (PBDIT) excl Other Income
1,627.67
0.00
1,627.67
Other Income
51.10
0
51.10
Operating Profit (PBDIT)
1,561.92
0
1,561.92
Interest
32.08
0
32.08
Exceptional Items
56.39
0
56.39
Gross Profit (PBDT)
4,689.26
0
4,689.26
Depreciation
0.00
0
0.00
Profit Before Tax
1,586.22
0
1,586.22
Tax
384.80
0
384.80
Provisions and contingencies
0
0
0.00
Profit After Tax
1,075.86
0
1,075.86
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,075.86
0
1,075.86
Share in Profit of Associates
0
0
0.00
Minority Interest
133.56
0
133.56
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,209.42
0
1,209.42
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
23,245.72
0
23,245.72
Earnings per share (EPS)
0.65
0
0.65
Diluted Earnings per share
0.65
0
0.65
Operating Profit Margin (Excl OI)
18.58%
0%
0.00
18.58%
Gross Profit Margin
19.51%
0%
0.00
19.51%
PAT Margin
13.23%
0%
0.00
13.23%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 812.98 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -15.46% vs 34.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 19.99% vs -6.14% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 120.94 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -4.52% vs 84.19% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -9.16% vs -8.38% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 151.08 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -4.80% vs 48.29% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -20.31% vs -2.59% in Mar 2025

Quarterly - Interest
Interest 3.21 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -10.34% vs 10.84% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 47.93% vs 4.33% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.58%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025